CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 250 of 701 entries

View as:

Remote Participation (Within USA) Trial of Sana Pain Reliever

Phase: N/A Priority: Normal

NCT ID: NCT04280562 Org: User:

Start: 01/16/20 End: 02/21/23 Due: 02/21/24

Women's INternational Transcatheter Aortic Valve Implantation Registry

Phase: N/A Priority: Normal

NCT ID: NCT01819181 Org: User:

Start: 03/31/13 End: 04/26/18 Due: 04/26/19

Reward Systems and Food Avoidance in Eating Disorders

Phase: N/A Priority: Normal

NCT ID: NCT02795455 Org: User:

Start: 11/30/16 End: 07/29/21 Due: 07/29/22

Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

Phase: N/A Priority: Normal

NCT ID: NCT00004479 Org: User:

Start: 03/31/99 End: - Due: -

Bimekizumab in Plaque Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT06336343 Org: User:

Start: 06/03/24 End: 10/31/25 Due: 10/31/26

Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency

Phase: N/A Priority: Normal

NCT ID: NCT00004695 Org: User:

Start: 09/30/97 End: 03/31/00 Due: 03/31/01

Immune Monitoring on Sipuleucel-T

Phase: N/A Priority: Normal

NCT ID: NCT02237170 Org: User:

Start: 06/30/12 End: 12/31/16 Due: 12/31/17

Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease

Phase: N/A Priority: Normal

NCT ID: NCT01291797 Org: User:

Start: 07/31/10 End: 06/30/11 Due: 06/30/12

Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)

Phase: N/A Priority: Normal

NCT ID: NCT02623829 Org: User:

Start: 12/01/15 End: 03/01/19 Due: 03/01/20

Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type

Phase: N/A Priority: Normal

NCT ID: NCT00824317 Org: User:

Start: 10/31/01 End: 02/28/05 Due: 02/28/06

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

Phase: N/A Priority: Normal

NCT ID: NCT03304080 Org: User:

Start: 12/20/17 End: 12/31/25 Due: 12/31/26

Impact of Intraoperative Cell Salvage

Phase: N/A Priority: Normal

NCT ID: NCT06240117 Org: User:

Start: 03/11/24 End: 05/31/26 Due: 05/31/27

Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis

Phase: N/A Priority: Normal

NCT ID: NCT07039019 Org: User:

Start: 06/04/25 End: 11/19/26 Due: 11/19/27

Paired Vagus Nerve Stimulation in Mobilization of Patients With Prolonged Disorders of Consciousness

Phase: N/A Priority: Normal

NCT ID: NCT06930716 Org: User:

Start: 05/31/25 End: 12/30/27 Due: 12/30/28

Switching Medication to Treat Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00044655 Org: User:

Start: 07/31/01 End: 03/31/09 Due: 03/31/10

Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities

Phase: N/A Priority: Normal

NCT ID: NCT00145197 Org: User:

Start: 01/31/04 End: 12/31/07 Due: 12/31/08

Behavioral and Pharmacological Reconsolidation Interference in Misophonia

Phase: N/A Priority: Normal

NCT ID: NCT05928689 Org: User:

Start: 06/02/23 End: 09/30/24 Due: 09/30/25

Neuroprotection in Patients Undergoing Aortic Valve Replacement

Phase: N/A Priority: Normal

NCT ID: NCT02389894 Org: User:

Start: 03/31/15 End: 01/31/17 Due: 01/31/18

Persuasive Health Communication Intervention for HIV/HCV

Phase: N/A Priority: Normal

NCT ID: NCT05968573 Org: User:

Start: 12/04/23 End: 12/08/27 Due: 12/08/28

Impact of Y90 Radiation Segmentectomy on HCC

Phase: N/A Priority: Normal

NCT ID: NCT03248375 Org: User:

Start: 08/03/16 End: 03/31/21 Due: 03/31/22

Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE

Phase: N/A Priority: Normal

NCT ID: NCT05873218 Org: User:

Start: 06/26/23 End: 04/30/26 Due: 04/30/27

A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism

Phase: N/A Priority: Normal

NCT ID: NCT05187377 Org: User:

Start: 01/19/22 End: 02/05/25 Due: 02/05/26

Cannabidiol in Sickle Cell Disease

Phase: N/A Priority: Normal

NCT ID: NCT06930703 Org: User:

Start: 04/03/25 End: 02/01/27 Due: 02/01/28

Eliminating Hepatitis C Virus

Phase: N/A Priority: Normal

NCT ID: NCT03401697 Org: User:

Start: 01/23/18 End: 03/01/21 Due: 03/01/22

The Prevent Coronary Artery Disease Trial

Phase: N/A Priority: Normal

NCT ID: NCT06494501 Org: User:

Start: 09/12/24 End: 06/30/32 Due: 06/30/33

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Remote Participation (Within USA) Trial of Sana Pain Reliever	NCT04280562	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2020-01-16	2023-02-21	2024-02-21	-	-	2025-07-14
Women's INternational Transcatheter Aortic Valve Implantation Registry	NCT01819181	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2013-03-31	2018-04-26	2019-04-26	-	-	2025-07-14
Reward Systems and Food Avoidance in Eating Disorders	NCT02795455	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2016-11-30	2021-07-29	2022-07-29	-	-	2025-07-14
Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope	NCT00004479	Icahn School of Medicine at Mount Sinai	user2@example.com	None	1999-03-31	-	-	-	-	2025-07-14
Bimekizumab in Plaque Psoriasis	NCT06336343	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2024-06-03	2025-10-31	2026-10-31	-	-	2025-07-14
Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency	NCT00004695	Icahn School of Medicine at Mount Sinai	user2@example.com	None	1997-09-30	2000-03-31	2001-03-31	-	-	2025-07-14
Immune Monitoring on Sipuleucel-T	NCT02237170	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2012-06-30	2016-12-31	2017-12-31	-	-	2025-07-14
Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease	NCT01291797	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2010-07-31	2011-06-30	2012-06-30	-	-	2025-07-14
Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)	NCT02623829	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2015-12-01	2019-03-01	2020-03-01	-	-	2025-07-14
Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type	NCT00824317	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2001-10-31	2005-02-28	2006-02-28	-	-	2025-07-14
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast	NCT03304080	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2017-12-20	2025-12-31	2026-12-31	-	-	2025-07-14
Impact of Intraoperative Cell Salvage	NCT06240117	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2024-03-11	2026-05-31	2027-05-31	-	-	2025-07-14
Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis	NCT07039019	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2025-06-04	2026-11-19	2027-11-19	-	-	2025-07-14
Paired Vagus Nerve Stimulation in Mobilization of Patients With Prolonged Disorders of Consciousness	NCT06930716	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2025-05-31	2027-12-30	2028-12-30	-	-	2025-07-14
Switching Medication to Treat Schizophrenia	NCT00044655	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2001-07-31	2009-03-31	2010-03-31	-	-	2025-07-14
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities	NCT00145197	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2004-01-31	2007-12-31	2008-12-31	-	-	2025-07-14
Behavioral and Pharmacological Reconsolidation Interference in Misophonia	NCT05928689	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2023-06-02	2024-09-30	2025-09-30	-	-	2025-07-14
Neuroprotection in Patients Undergoing Aortic Valve Replacement	NCT02389894	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2015-03-31	2017-01-31	2018-01-31	-	-	2025-07-14
Persuasive Health Communication Intervention for HIV/HCV	NCT05968573	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2023-12-04	2027-12-08	2028-12-08	-	-	2025-07-14
Impact of Y90 Radiation Segmentectomy on HCC	NCT03248375	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2016-08-03	2021-03-31	2022-03-31	-	-	2025-07-14
Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE	NCT05873218	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2023-06-26	2026-04-30	2027-04-30	-	-	2025-07-14
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism	NCT05187377	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2022-01-19	2025-02-05	2026-02-05	-	-	2025-07-14
Cannabidiol in Sickle Cell Disease	NCT06930703	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2025-04-03	2027-02-01	2028-02-01	-	-	2025-07-14
Eliminating Hepatitis C Virus	NCT03401697	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2018-01-23	2021-03-01	2022-03-01	-	-	2025-07-14
The Prevent Coronary Artery Disease Trial	NCT06494501	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2024-09-12	2032-06-30	2033-06-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance